{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:00:06Z","timestamp":1791824406692,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":547,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.exphem.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T11:34:00Z","timestamp":1662723240000},"page":"30-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-1384","authenticated-orcid":false,"given":"Tharshika","family":"Thavayogarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzmitry","family":"Sinitski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-2096","authenticated-orcid":false,"given":"Omar","family":"El Bounkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Torres-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Lewinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Harjung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Vankann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idit","family":"Shachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-2652","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Bernhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Koschmieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2022.08.005_bib0001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","article-title":"B-Cell chronic lymphocytic leukemia: A bird of a different feather","volume":"17","author":"Caligaris-Cappio","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0002","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(08)60456-0","article-title":"Chronic lymphocytic leukaemia","volume":"371","author":"Dighiero","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2022.08.005_bib0003","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrc.2016.8","article-title":"Dalla-Favera R. The molecular pathogenesis of chronic lymphocytic leukaemia","volume":"16","author":"Fabbri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2022.08.005_bib0004","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2022.08.005_bib0005","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.96.9.5215","article-title":"Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages","volume":"96","author":"Lee","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.exphem.2022.08.005_bib0006","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V100.5.1795.h81702001795_1795_1801","article-title":"Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1","volume":"100","author":"Pedersen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0007","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: A target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0008","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \u201cnurselike\u201d cells that differentiate in the context of chronic lymphocytic leukemia","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0009","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2012-05-431452","article-title":"Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor","volume":"121","author":"Reinart","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.cdd.4401653","article-title":"MIF loss impairs Myc-induced lymphomagenesis","volume":"12","author":"Talos","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2022.08.005_bib0011","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0090-4295(96)00207-5","article-title":"Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases","volume":"48","author":"Meyer-Siegler","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.exphem.2022.08.005_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2407-7-135","article-title":"Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice","volume":"7","author":"Taylor","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2022.08.005_bib0013","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.lungcan.2004.05.013","article-title":"Translating biomarkers into clinical practice: Prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer","volume":"46","author":"Howard","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.exphem.2022.08.005_bib0014","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2022.08.005_bib0015","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1073\/pnas.0701553104","article-title":"IL-8 secreted in a macrophage migration-inhibitory factor-and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival","volume":"104","author":"Binsky","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.exphem.2022.08.005_bib0016","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ncb1838","article-title":"Lippincott-Schwartz J. Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche","volume":"11","author":"Gillette","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0017","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1272\/jnms.76.198","article-title":"Dextran sulfate and stromal cell derived factor-1 promote CXCR4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells","volume":"76","author":"Hayakawa","year":"2009","journal-title":"J Nippon Med School"},{"key":"10.1016\/j.exphem.2022.08.005_bib0018","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3324\/haematol.12553","article-title":"Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model","volume":"93","author":"Kyriakou","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2022.08.005_bib0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/382833a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell-line-adapted HIV-1","volume":"382","author":"Oberlin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.08.005_bib0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1 is a ligand for LESTR\/fusin and blocks HIV-1 entry","volume":"382","author":"Bleul","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.08.005_bib0021","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2022.08.005_bib0022","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0023","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.M703265200","article-title":"Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex","volume":"283","author":"Gore","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2022.08.005_bib0024","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.279.5349.381","article-title":"Chemokines and the arrest of lymphocytes rolling under flow conditions","volume":"279","author":"Campbell","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.exphem.2022.08.005_bib0025","doi-asserted-by":"crossref","first-page":"e11716","DOI":"10.1371\/journal.pone.0011716","article-title":"Elucidating the CXCL12\/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis","volume":"5","author":"O'Hayre","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.exphem.2022.08.005_bib0026","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fimmu.2015.00429","article-title":"Diversity and inter-connections in the CXCR4 chemokine receptor\/ligand family: Molecular perspectives","volume":"6","author":"Pawig","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0027","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3324\/haematol.2011.052779","article-title":"AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: Pre-clinical evidence for its association with chronic lymphocytic leukemia treatments","volume":"97","author":"Stamatopoulos","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2022.08.005_bib0028","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V116.21.2450.2450","article-title":"Preliminary results from a phase I dose escalation study to determine the maximum tolerated dose of plerixafor in combination with rituximab in patients with relapsed chronic lymphocytic leukemia","volume":"116","author":"Andritsos","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0029","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/blood-2005-11-4334","article-title":"Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival","volume":"107","author":"Starlets","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0030","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1182\/blood-2007-04-087486","article-title":"CD74 induces TAp63 expression leading to B-cell survival","volume":"110","author":"Lantner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0031","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2009-11-253203","article-title":"Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells","volume":"116","author":"Hertlein","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0032","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-020-03144-y","article-title":"Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance","volume":"11","author":"Kapoor","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.exphem.2022.08.005_bib0033","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute\u2013Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0034","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0035","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.exphem.2022.08.005_bib0036","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.1302209","article-title":"MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling","volume":"192","author":"Klasen","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0037","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1158\/0008-5472.CAN-12-3564","article-title":"CIP4 controls CCL19-driven cell steering and chemotaxis in chronic lymphocytic leukemia","volume":"73","author":"Malet-Engra","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2022.08.005_bib0038","doi-asserted-by":"crossref","first-page":"14144","DOI":"10.1021\/bi00251a025","article-title":"Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)","volume":"33","author":"Bernhagen","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.exphem.2022.08.005_bib0039","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","article-title":"A functional heteromeric MIF receptor formed by CD74 and CXCR4","volume":"583","author":"Schwartz","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2022.08.005_bib0040","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1096\/fj.15-273904","article-title":"MIF interacts with CXCR7 to promote receptor internalization, ERK1\/2 and ZAP-70 signaling, and lymphocyte chemotaxis","volume":"29","author":"Alampour-Rajabi","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.exphem.2022.08.005_bib0041","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1038\/s41598-018-23554-5","article-title":"Identification of an Arg\u2013Leu\u2013Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4","volume":"8","author":"Lacy","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2022.08.005_bib0042","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"Azab","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0043","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.3748\/wjg.v16.i26.3258","article-title":"CD74 is a survival receptor on colon epithelial cells","volume":"16","author":"Maharshak","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0044","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12032-013-0560-5","article-title":"High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients","volume":"30","author":"Butrym","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0045","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.4049\/jimmunol.177.11.7833","article-title":"Evidence for NK cell subsets based on chemokine receptor expression","volume":"177","author":"Berahovich","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0046","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1002\/eji.200425587","article-title":"Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation","volume":"34","author":"Kobayashi","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0047","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1200\/JCO.2007.15.4393","article-title":"Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?","volume":"26","author":"Caligaris-Cappio","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2022.08.005_bib0048","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1080\/10428194.2020.1791851","article-title":"CD74 is dispensable for development of chronic lymphocytic leukemia in Emicro-TCL1 transgenic mice","volume":"61","author":"Barthel","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2022.08.005_bib0049","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","article-title":"Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)","volume":"13","author":"M\u00f6hle","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2022.08.005_bib0050","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells","volume":"106","author":"Burger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0051","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0052","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/leu.2015.316","article-title":"BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia","volume":"30","author":"Chen","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2022.08.005_bib0053","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cellsig.2003.07.002","article-title":"Mechanisms and effectors of MIF-dependent promotion of tumourigenesis","volume":"16","author":"Mitchell","year":"2004","journal-title":"Cellular Signal"},{"key":"10.1016\/j.exphem.2022.08.005_bib0054","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.190.10.1375","article-title":"A proinflammatory cytokine inhibits p53 tumor suppressor activity","volume":"190","author":"Hudson","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2022.08.005_bib0055","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","article-title":"Phosphatidylinositol 3-kinase-\u03b4 inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals","volume":"116","author":"Herman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.08.005_bib0056","doi-asserted-by":"crossref","first-page":"27203","DOI":"10.1074\/jbc.M104684200","article-title":"Invariant chain induces B cell maturation by activating a TAFII105-NF-\u03baB-dependent transcription program","volume":"276","author":"Matza","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22006816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22006816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:37:43Z","timestamp":1759567063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X22006816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":56,"alternative-id":["S0301472X22006816"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2022.08.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 ISEH \u2013 Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}